PIK3CA and CDH1-related diffuse gastric and lobular breast cancer syndrome: Oncogenic PIK3CA mutations frequently occur in a higher proportion in LBC, especially in refractory advanced patients, which predicts unfavourable efficacy of immunotherapy in cancers.51